US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
Cancer biomarkers are substances or processes that are indicative of the presence of cancers in the human body. Biomarkers may be produced by the cancer tissue itself or by other cells in the body in response to cancer. They can be found in the blood, stool, urine, tumor tissue, or other tissues or bodily fluids. In terms of applications, diagnostics accounted for major share of the global cancer biomarkers market in 2017. The global Cancer Biomarker market is valued at 11600 million US$ in 2018 is expected to reach 29300 million US$ by the end of 2025, growing at a CAGR of 12.3% during 2019-2025. This report focuses on Cancer Biomarker volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Biomarker market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Thermo Fisher Scientific Bio-Rad Laboratories Roche Diagnostics Qiagen Illumina GE Healthcare Agilent Technologies Biomérieux SA Merck & Co. Abbott Laboratories Becton, Dickinson and Company Danaher Corporation Myriad Genetics Sysmex Corporation Hologic Quest Diagnostics Segment by Regions North America Europe China Japan Segment by Type Protein Biomarker Genetic Biomarker Segment by Application Diagnostics Research Prognostics Risk Assessment Other Applications
Table of Contents Executive Summary 1 Cancer Biomarker Market Overview 1.1 Product Overview and Scope of Cancer Biomarker 1.2 Cancer Biomarker Segment by Type 1.2.1 Global Cancer Biomarker Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Protein Biomarker 1.2.3 Genetic Biomarker 1.3 Cancer Biomarker Segment by Application 1.3.1 Cancer Biomarker Consumption Comparison by Application (2014-2025) 1.3.2 Diagnostics 1.3.3 Research 1.3.4 Prognostics 1.3.5 Risk Assessment 1.3.6 Other Applications 1.4 Global Cancer Biomarker Market by Region 1.4.1 Global Cancer Biomarker Market Size Region 1.4.2 North America Status and Prospect (2014-2025) 1.4.3 Europe Status and Prospect (2014-2025) 1.4.4 China Status and Prospect (2014-2025) 1.4.5 Japan Status and Prospect (2014-2025) 1.5 Global Cancer Biomarker Market Size 1.5.1 Global Cancer Biomarker Revenue (2014-2025) 1.5.2 Global Cancer Biomarker Production (2014-2025) 2 Global Cancer Biomarker Market Competition by Manufacturers 2.1 Global Cancer Biomarker Production Market Share by Manufacturers (2014-2019) 2.2 Global Cancer Biomarker Revenue Share by Manufacturers (2014-2019) 2.3 Global Cancer Biomarker Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Cancer Biomarker Production Sites, Area Served, Product Types 2.5 Cancer Biomarker Market Competitive Situation and Trends 2.5.1 Cancer Biomarker Market Concentration Rate 2.5.2 Cancer Biomarker Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Cancer Biomarker Production Market Share by Regions 3.1 Global Cancer Biomarker Production Market Share by Regions 3.2 Global Cancer Biomarker Revenue Market Share by Regions (2014-2019) 3.3 Global Cancer Biomarker Production, Revenue, Price and Gross Margin (2014-2019) 3.4 North America Cancer Biomarker Production 3.4.1 North America Cancer Biomarker Production Growth Rate (2014-2019) 3.4.2 North America Cancer Biomarker Production, Revenue, Price and Gross ... | read more...